FDA Brief

Warning letters Food

FDA warning letter to

Applied Health Solutions, Inc.

LowIssued Oct 22, 2021Posted Feb 1, 2022Office of Human and Animal Food Operations - Division IV West

FDA warned Applied Health Solutions that website claims made its supplements unapproved drugs for diseases including MRSA, AIDS, and arthritis.

What happened

FDA reviewed the company’s websites in July-August 2021 and found it took orders there for B Complex, Daily Detox, CellRenewPRO, CellRenewSTS, PowerZyme Prime, and two NutriBiotic grapefruit seed extract products. FDA cited website statements that these products cure, mitigate, treat, or prevent diseases such as MRSA infection, colds and flu, AIDS, cancer, arthritis, and Candida. FDA said these claims make the products drugs and that selling them for these uses violates the Act.

What FDA found

  1. Website claims said B Complex helps prevent MRSA infection by boosting immunity.

    FD&C Act § 201(g)(1)(B) [21 U.S.C. § 321(g)(1)(B)]
  2. Website claims said Daily Detox fights bacterial, viral, and fungal infections and protects against colds and flu.

    FD&C Act § 201(g)(1)(B) [21 U.S.C. § 321(g)(1)(B)]
  3. Website claims said PowerZyme Prime inhibits Candida and has anti-inflammatory and blood-clot-prevention effects.

    FD&C Act § 201(g)(1)(B) [21 U.S.C. § 321(g)(1)(B)]
  4. Website claims said Grapefruit Seed Extract products fight infections, AIDS, cancer, colds, flu, parasites, and diarrhea.

    FD&C Act § 201(g)(1)(B) [21 U.S.C. § 321(g)(1)(B)]
  5. Website claims said CellRenewPRO and CellRenewSTS repair joints, relieve arthritis pain and inflammation, and may benefit heart disease and psoriasis.

    FD&C Act § 201(g)(1)(B) [21 U.S.C. § 321(g)(1)(B)]
  6. FDA determined the website claims establish the products are intended for disease treatment or prevention, making them drugs under the Act.

    FD&C Act § 201(g)(1)(B) [21 U.S.C. § 321(g)(1)(B)]

What FDA wants

FDA tells the company that selling these products for the cited disease uses violates the Act, so it should correct the website claims and product marketing. No response deadline is stated in the provided letter text.

Who should pay attention

  • dietary supplement brands making disease-treatment claims
  • retailers and online marketplaces selling supplement products
  • companies that publish health blogs linking to product pages

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk